Difference between revisions of "Pandharipande PP, et al, Crit Care Med (2004), cited as Ref 35 in DOI: 10.1186/s13054-020-02882-x (Q10666)"
Jump to navigation
Jump to search
(Created claim: Published In Name String (P102): Crit Care Med, #quickstatements; #temporary_batch_1592746890515) |
(Created claim: Volume (P103): 32, #quickstatements; #temporary_batch_1592746995751) |
||
| Property / Volume | |||
| + | 32 | ||
| Property / Volume: 32 / rank | |||
| + | Normal rank | ||
Revision as of 13:44, 21 June 2020
Cited in: "COVID-19: ICU delirium management during SARS-CoV-2 pandemic" Crit Care; 2020 04 28 ; 24 (1) 176
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Pandharipande PP, et al, Crit Care Med (2004), cited as Ref 35 in DOI: 10.1186/s13054-020-02882-x
|
Cited in: "COVID-19: ICU delirium management during SARS-CoV-2 pandemic" Crit Care; 2020 04 28 ; 24 (1) 176
|
Statements
Sedative and analgesic medications are independent risk factors in ICU patients for transitioning into delirium (English)
0 references
2004
0 references
Pandharipande PP
0 references
Shintani A
0 references
Peterson J
0 references
Ely EW
0 references
Crit Care Med
0 references
32
0 references
